Related Experiment Video

Updated: Jul 15, 2026

Forward Genetic Approaches in Chlamydia trachomatis
09:03

Forward Genetic Approaches in Chlamydia trachomatis

Published on: October 23, 2013

Hydroxymethylglutaryl coenzyme A reductase inhibition reduces Chlamydia pneumoniae-induced cell interaction and

Ralf Dechend1, Jens Gieffers, Rainer Dietz

  • 1Franz Volhard Clinic at the Max Delbrück Center for Molecular Medicine, HELIOS Klinikum-Berlin, Wiltberg Strasse 50, 13125 Berlin, Germany. dechend@fvk-berlin.de

Circulation
|July 16, 2003
PubMed
Abstract

Insights

Statins reduce Chlamydia pneumoniae transmission from macrophages to vascular cells. This treatment mitigates atherosclerosis-like inflammatory responses in vascular smooth muscle cells (VSMCs) by blocking key signaling pathways.

Area of Science:

  • Cardiovascular Research
  • Infectious Disease Immunology
  • Pharmacology

Background:

  • Chlamydia pneumoniae infection is linked to chronic inflammation in vascular cells.
  • Hydroxymethylglutaryl coenzyme A reductase inhibitors (statins) may offer protective effects against this inflammation.
  • The precise mechanisms by which statins affect C. pneumoniae-induced vascular changes require investigation.

Purpose of the Study:

  • To investigate the mechanisms by which statins ameliorate Chlamydia pneumoniae-induced inflammation in vascular cells.
  • To determine if statins can reduce the transmission of C. pneumoniae from macrophages to vascular smooth muscle cells (VSMCs).
  • To elucidate the effects of statins on specific cellular signaling pathways activated by C. pneumoniae infection in VSMCs.

Main Methods:

  • Human macrophages were infected with C. pneumoniae and co-cultured with VSMCs to model infection transmission.
  • VSMC infection and associated molecular changes were assessed after treatment with cerivastatin (a statin).
  • Key molecular markers including RhoA, Rac1, reactive oxygen species (ROS), nuclear transcription factor-kappaB (NF-κB), and chemokines (RANTES, MCP-1) were quantified.

Main Results:

  • Cerivastatin significantly reduced VSMC infection by C. pneumoniae.
  • Statin treatment inhibited the prenylation of RhoA and Rac1, and this effect was reversed by mevalonate.
  • Statins decreased ROS production, suppressed NF-κB activation, and reduced the production of RANTES and MCP-1 in infected VSMCs, with these effects being circumvented by mevalonate or geranylgeranylpyrophosphate.

Conclusions:

  • C. pneumoniae can be transmitted from infected macrophages to VSMCs, inducing an atherosclerotic-like activation profile.
  • This activation includes RhoA/Rac1 prenylation, NF-κB signaling, ROS generation, and chemokine release.
  • Statins effectively reduce C. pneumoniae-induced signaling and transmission in this model, highlighting their potential therapeutic role in managing vascular inflammation associated with this infection.

More Related Videos

Using Fluorescent Proteins to Visualize and Quantitate Chlamydia Vacuole Growth Dynamics in Living Cells07:42

Using Fluorescent Proteins to Visualize and Quantitate Chlamydia Vacuole Growth Dynamics in Living Cells

Published on: October 13, 2015

Live-Cell Forward Genetic Approach to Identify and Isolate Developmental Mutants in Chlamydia trachomatis10:32

Live-Cell Forward Genetic Approach to Identify and Isolate Developmental Mutants in Chlamydia trachomatis

Published on: June 10, 2020

Related Concept Videos

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic of...
Trichomoniasis01:18

Trichomoniasis

Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.